[go: up one dir, main page]

DE69109292D1 - Verminderung oder verhütung der von arzneimitteln verursachten hautreizung. - Google Patents

Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.

Info

Publication number
DE69109292D1
DE69109292D1 DE69109292T DE69109292T DE69109292D1 DE 69109292 D1 DE69109292 D1 DE 69109292D1 DE 69109292 T DE69109292 T DE 69109292T DE 69109292 T DE69109292 T DE 69109292T DE 69109292 D1 DE69109292 D1 DE 69109292D1
Authority
DE
Germany
Prior art keywords
drug
skin
irritation
prevention
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69109292T
Other languages
English (en)
Other versions
DE69109292T2 (de
Inventor
Michel Cormier
Philip Ledger
Alfred Amkraut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69109292D1 publication Critical patent/DE69109292D1/de
Application granted granted Critical
Publication of DE69109292T2 publication Critical patent/DE69109292T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Packaging For Recording Disks (AREA)
  • Passenger Equipment (AREA)
DE69109292T 1990-07-06 1991-07-01 Verminderung oder verhütung der von arzneimitteln verursachten hautreizung. Expired - Fee Related DE69109292T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/549,584 US5130139A (en) 1990-07-06 1990-07-06 Reduction or prevention of skin irritation by drugs
PCT/US1991/004685 WO1992000746A1 (en) 1990-07-06 1991-07-01 Reduction or prevention of skin irritation by drugs

Publications (2)

Publication Number Publication Date
DE69109292D1 true DE69109292D1 (de) 1995-06-01
DE69109292T2 DE69109292T2 (de) 1995-08-31

Family

ID=24193593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69109292T Expired - Fee Related DE69109292T2 (de) 1990-07-06 1991-07-01 Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.

Country Status (18)

Country Link
US (1) US5130139A (de)
EP (1) EP0538302B1 (de)
JP (1) JP3224814B2 (de)
AT (1) ATE121627T1 (de)
AU (1) AU641787B2 (de)
CA (1) CA2046014C (de)
DE (1) DE69109292T2 (de)
DK (1) DK0538302T3 (de)
ES (1) ES2071322T3 (de)
FI (1) FI930038A7 (de)
GR (1) GR3015934T3 (de)
IE (1) IE74152B1 (de)
MX (1) MX9100042A (de)
NO (1) NO925038L (de)
NZ (1) NZ238804A (de)
PT (1) PT98177B (de)
WO (1) WO1992000746A1 (de)
ZA (1) ZA915067B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100074C (en) * 1991-11-08 2003-08-12 Yasushi Sekiyama Biocidal self-adhesive and process for producing the same, as well as self-adhesive article and application thereof
US5843979A (en) * 1993-02-25 1998-12-01 Bristol-Myers Squibb Company Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
IL109036A (en) * 1993-03-19 1998-12-27 Cellegy Pharamaceuticals Inc Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations
US6190894B1 (en) 1993-03-19 2001-02-20 The Regents Of The University Of California Method and compositions for disrupting the epithelial barrier function
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
EP0752898B1 (de) 1994-03-30 1998-04-29 Alza Corporation Verminderung der hautreizung während einer iontophoretischen abgabe von medikamenten
WO1995034262A1 (en) * 1994-06-16 1995-12-21 Department Of The Army, Us Government Transdermal treatment of malaria
US5686100A (en) * 1994-11-22 1997-11-11 E.R. Squibb & Sons, Inc. Prophylactic and therapeutic treatment of skin sensitization and irritation
WO1997047355A1 (en) * 1996-06-12 1997-12-18 Alza Corporation Reduction of skin sensitization in electrotransport drug delivery
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
US5981168A (en) 1998-05-15 1999-11-09 The University Of British Columbia Method and composition for modulating amyloidosis
US6699497B1 (en) * 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
EP1802258A4 (de) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Biosynchrone transdermale arzneiabgabe
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
EP2106353B1 (de) 2007-01-25 2014-01-08 Honda Motor Co., Ltd. Fahrzeugsystemsteuerung für erhöhte stabilität
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
MX359921B (es) * 2013-02-08 2018-10-16 Luoda Pharma Pty Ltd Métodos de tratamiento tópico para infecciones microbianas.
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
EP3565617A1 (de) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Vorrichtungen und verfahren zur transdermalen wirkstofffreisetzung
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
WO2020102695A1 (en) 2018-11-16 2020-05-22 Cti (Assignment For Benefit Of Creditors) Llc Thermally regulated transdermal drug delivery system

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4325367A (en) * 1977-06-13 1982-04-20 Robert Tapper Iontophoretic treatment apparatus
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
CA1153427A (en) * 1978-12-11 1983-09-06 Patrick T. Cahalan Tape electrode
JPS56501274A (de) * 1979-10-10 1981-09-10
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
GB2124485B (en) * 1982-08-04 1986-06-04 Michael A Levy Penetrating topical medicament
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
US4702732A (en) * 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
PT94402A (pt) * 1989-06-19 1991-03-20 Wellcome Found Processo para a preparacao de compostos azotados que contem sistemas de aneis ciclicos aromaticos e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
PT98177A (pt) 1993-08-31
GR3015934T3 (en) 1995-07-31
PT98177B (pt) 1998-12-31
ATE121627T1 (de) 1995-05-15
AU8104691A (en) 1992-02-04
FI930038L (fi) 1993-01-05
EP0538302A1 (de) 1993-04-28
CA2046014A1 (en) 1992-01-07
DK0538302T3 (da) 1995-09-18
JPH05508643A (ja) 1993-12-02
MX9100042A (es) 1992-02-28
NO925038D0 (no) 1992-12-30
US5130139A (en) 1992-07-14
WO1992000746A1 (en) 1992-01-23
IE74152B1 (en) 1997-07-02
CA2046014C (en) 2003-05-20
AU641787B2 (en) 1993-09-30
FI930038A0 (fi) 1993-01-05
ZA915067B (en) 1992-04-29
JP3224814B2 (ja) 2001-11-05
FI930038A7 (fi) 1993-01-05
IE912294A1 (en) 1992-01-15
NZ238804A (en) 1992-08-26
DE69109292T2 (de) 1995-08-31
EP0538302B1 (de) 1995-04-26
NO925038L (no) 1993-01-06
ES2071322T3 (es) 1995-06-16

Similar Documents

Publication Publication Date Title
DE69109292D1 (de) Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.
WO1992002234A3 (en) Reduction or prevention of sensitization to drugs
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
NO944249L (no) Transdermal administrering av oksybutynin
ES2141706T3 (es) Formulaciones y su empleo en el tratamiento de enfermedades neurologicas.
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
BR9306841A (pt) Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
DE69634609D1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu-opioidanagonisten und eines kappa - 2- opioidanagonisten
ATE262325T1 (de) Kosmetische, pharmazeutische oder dermatologische zusammensetzung, sowie die zusammensetzung alpha- tnfantagonisten enthaltend
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
EP1441799A4 (de) Vorrichtung und verfahren zur abgabe von mikrodosen eines medikaments in das ohr
PT904067E (pt) Dextrometorfan como agente antitussico administrado transdermicamente
DE69400353D1 (de) Schlankmachende Zusammensetzung
DE3685696D1 (de) Melatoninhaltige mittel sowie deren verwendungen.
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
GB8923254D0 (en) Medicaments
BR9914792A (pt) Uso de agentes antifúngicos para tratamento deescleroses
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee